Press Releases

SAN DIEGO, Oct. 21, 2019 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will webcast its Quarterly Update Conference Call for the third quarter 2019 on Tuesday, November 12 at 4:30 p.m. ET / 1:30 p.

ColoGuard, owned by Exact Sciences is one of the most successful genomics companies in the World, currently listed on the Nasdaq with a market cap of USD 12 Billion. ColoClear will be the region's 1st non-invasive DNA stool test to screen for colorectal cancer at 92%,which can be done in the comfort of your own home. Genomics industry in Asia

HOUSTON, Oct. 21, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announces it will host a webcast to present the compa

Now Available at Major U.S. Retailers BRIDGEWATER, N.J., Oct. 21, 2019 /PRNewswire/ -- Bausch + Lomb, a leading global eye health company and wholly owned subsidiary of Bausch Health Companies Inc. (NYSE/TXS: BHC), today announced the U.S. launch of PreserVision® AREDS 2 Formula minigel eye vitamins. The new minigels will replace the currentl

HORSHAM, Pa., Oct. 21, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration's (FDA) approval of STELARA® (ustekinumab) for the treatment of adult patients with moderately to severely active ulcerative colitis. The approval for this new indication is based on the pivotal Pha

SUNNYVALE, Calif., Oct. 21, 2019 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that Suzanne Winter has joined the company as Senior Vice President, Chief Commercial Officer effective October 21, 2019. Ms. Winter will have global responsibility for the commercial function reporting to

MALVERN, Pa., Oct. 21, 2019 /PRNewswire/ -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, announced today it will ring the Nasdaq Closing Bell on October 22

OAKLAND, CA and TORONTO, Oct. 21, 2019 /PRNewswire/ - Harborside Inc. ("Harborside" or the "Company") (CSE: HBOR), today announced that the U.S. Tax Court has issued a final decision under Tax Court Rule 155 on the income tax deficiency for Patients Mutual Assistance Collective Corporation ("PMACC"), the Company's 100% owned subsidiary an

ANN ARBOR, Mich., Oct. 21, 2019 /PRNewswire/ -- Domino's (NYSE: DPZ), the largest pizza company in the world based on global retail sales, is ready to raise funds for St. Jude Children's Research Hospital® online and in stores across the country. The campaign, which begins today and runs for 11 weeks through Jan

MARINA DEL REY, Calif., Oct. 21, 2019 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that it has received a Research and Development (R&D) Tax Incentive cash rebate of USD